TAVI: emerging evidence

Session comprising selected PCR London Valves 2022 Abstract submissions

Facilitators: D. Dvir, M. Barbanti

Summary

Through the 5 abstracts of this PCR LV 2022 session, follow the comparison between last-generation balloon and self-expandable TAVR for bicuspid aortic valve stenosis, and the comparison between multiple tools to assess the risk of mortality after TAVR, evaluate the impact of post-TAVI vascular complications, and analyze the trends in survival after TAVR, among many other interesting topics!

Presentations available when logged in:

  • Mortality after TAVR in the ENVISAGE-TAVI AF trial: A comparison of multiple risk assessment tools
  • Trends in survival after TAVR
  • Comparison of last-generation balloon and self-expandable TAVR for bicuspid aortic valve stenosis
  • Transcatheter aortic valve positioning and outcome in redo-TAVI
  • Impact of vascular complications after TAVI